Teresa O'Meara, PhD
Assistant Professor of Microbiology and Immunology
[email protected]

Available to mentor

Teresa O'Meara, PhD
Assistant Professor
  • About
  • Links
  • Qualifications
  • Research Overview
  • Recent Publications
  • About

    Teresa O’Meara, PhD, is an Assistant Professor of Microbiology and Immunology at the University of Michigan. Her lab is interested in how fungal pathogens are able to cause disease, and uses genetics approaches to tackle this problem. The main pathogens in the lab are Candida albicans and Candida auris. Currently, their NIH-funded projects include understanding mechanisms of adherence in Candida auris, and using co-expression and evolutionary perspectives to understand gene function in emerging fungal pathogens.

    Teresa received her BA from the University of Chicago, graduating with honors in Biology. She completed her PhD in Genetics and Genomics from Duke University, where she was supported by an American Heart Association predoctoral fellowship for her work on Cryptococcus neoformans signal transduction cascades and virulence. Her postdoctoral studies at the University of Toronto were supported by an NIH F32 fellowship to use global chemical genetics and proteomic approaches to understand the role of Hsp90 in Candida albicans virulence, drug resistance, and morphology. She also worked on understanding the mechanisms by which Candida albicans can filament and drive host cell death.

    Links
    • O'Meara Lab
    • Google Scholar
    • Pub Med
    Qualifications
    • Postdoctoral Researcher
      University of Toronto, Molecular Genetics, 2019
    • Visiting Postdoctoral Researcher
      University of California San Francisco, Microbiology and Immunology, 2019
    • PhD
      Duke University, Durham, 2013
    • AB
      University of Chicago, Chicago, 2007
    Research Overview

    The O'Meara lab is interested in how organisms can sense and respond to the environment, with a particular focus on how fungal pathogens adapt to the stresses of a human host. More specifically, we want to understand how fungal pathogens are able to cause disease in humans. This includes asking questions about host-pathogen interactions and the evolution and selective pressures driving pathogenesis. We use functional genomics and genetic approaches to answer these questions. We primarily work on Candida auris, Candida albicans, and Cryptococcus neoformans.

    Recent Publications See All Publications
    • Journal Article
      Non-canonical activation of IRE1α during Candida albicans infection enhances macrophage fungicidal activity.
      McFadden MJ, Reynolds MB, Michmerhuizen BC, Ólafsson EB, Anderson FM, Schultz TL, O'Riordan MXD, O'Meara TR. bioRxiv, 2024 May 2; DOI:10.1101/2023.10.02.560560
      PMID: 37873171
    • Journal Article
      CryptoCEN: A Co-Expression Network for Cryptococcus neoformans reveals novel proteins involved in DNA damage repair.
      O'Meara MJ, Rapala JR, Nichols CB, Alexandre AC, Billmyre RB, Steenwyk JL, Alspaugh JA, O'Meara TR. PLoS Genet, 2024 Feb; 20 (2): e1011158 DOI:10.1371/journal.pgen.1011158
      PMID: 38359090
    • Journal Article
      A Candida auris-specific adhesin, Scf1, governs surface association, colonization, and virulence.
      Santana DJ, Anku JAE, Zhao G, Zarnowski R, Johnson CJ, Hautau H, Visser ND, Ibrahim AS, Andes D, Nett JE, Singh S, O'Meara TR. Science, 2023 Sep 29; 381 (6665): 1461 - 1467. DOI:10.1126/science.adf8972
      PMID: 37769084
    • Journal Article
      Imaging-Based Screening Identifies Modulators of the eIF3 Translation Initiation Factor Complex in Candida albicans.
      Metzner K, O'Meara MJ, Halligan B, Wotring JW, Sexton JZ, O'Meara TR. Antimicrob Agents Chemother, 2023 Jul 18; 67 (7): e0050323 DOI:10.1128/aac.00503-23
      PMID: 37382550
    • Journal Article
      Candida albicans selection for human commensalism results in substantial within-host diversity without decreasing fitness for invasive disease.
      Anderson FM, Visser ND, Amses KR, Hodgins-Davis A, Weber AM, Metzner KM, McFadden MJ, Mills RE, O'Meara MJ, James TY, O'Meara TR. PLoS Biol, 2023 May; 21 (5): e3001822 DOI:10.1371/journal.pbio.3001822
      PMID: 37205709
    • Journal Article
      Forward and reverse genetic dissection of morphogenesis identifies filament-competent Candida auris strains.
      Santana DJ, O'Meara TR. Nat Commun, 2021 Dec 10; 12 (1): 7197 DOI:10.1038/s41467-021-27545-5
      PMID: 34893621
    • Journal Article
      Germination of a Field: Women in Candida albicans Research
      Anderson FM, Polvi EJ, Veri AO, O’Meara TR. Current Clinical Microbiology Reports, 2021 Sep 1; 8 (3): 139 - 151. DOI:10.1007/s40588-021-00169-5
    • Journal Article
      Adaptive immunity induces mutualism between commensal eukaryotes.
      Ost KS, O'Meara TR, Stephens WZ, Chiaro T, Zhou H, Penman J, Bell R, Catanzaro JR, Song D, Singh S, Call DH, Hwang-Wong E, Hanson KE, Valentine JF, Christensen KA, O'Connell RM, Cormack B, Ibrahim AS, Palm NW, Noble SM, Round JL. Nature, 2021 Aug; 596 (7870): 114 - 118. DOI:10.1038/s41586-021-03722-w
      PMID: 34262174
    Featured News & Stories Microscopic rendering of the flu virus with green, purple and red coloring
    News Release
    $10 million NIH-award establishes new U-M center to study genomics of infectious disease pathogens
    A new NIH award will establish the Michigan Infectious Disease Genomics (MIDGE) Center, the goal of which is to use whole genome sequencing and functional genomic assays to determine how genetic differences among strains or isolates affect the behavior, transmission, and drug resistance of viral, bacterial, and fungal pathogens.
    Photo portrait of Teresa O'Meara
    Department News
    Teresa O'Meara, Ph.D., is a recipient of the Investigators in the Pathogenesis of Infectious Disease (PATH) program of the Burroughs Wellcome Fund
    M&I Teresa O'Meara is a recipient of of the Investigators in the Pathogenesis of Infectious Disease (PATH) program of the Burroughs Wellcome Fund. Her lab will further study the mechanisms of attachment and virulence for C. auris, with a focus on how the novel adhesin contributes to pathogenesis. On a practical level, their work will suggest strategies for developing vaccine candidates and therapeutics to limit disease caused by this emerging pathogen.